MedPath

Cisatracurium Besylate

These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 1995

Approved
Approval ID

7073cb55-f766-4092-a10b-c2cb2863a044

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 23, 2023

Manufacturers
FDA

Hospira, Inc.

DUNS: 141588017

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CISATRACURIUM BESYLATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-7083
Application NumberANDA203238
Product Classification
M
Marketing Category
C73584
G
Generic Name
CISATRACURIUM BESYLATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 5, 2022
FDA Product Classification

INGREDIENTS (4)

CISATRACURIUM BESYLATEActive
Quantity: 2 mg in 1 mL
Code: 80YS8O1MBS
Classification: ACTIM
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
BENZENESULFONIC ACIDInactive
Code: 685928Z18A
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

CISATRACURIUM BESYLATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-3670
Application NumberANDA203236
Product Classification
M
Marketing Category
C73584
G
Generic Name
CISATRACURIUM BESYLATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 5, 2022
FDA Product Classification

INGREDIENTS (3)

CISATRACURIUM BESYLATEActive
Quantity: 10 mg in 1 mL
Code: 80YS8O1MBS
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZENESULFONIC ACIDInactive
Code: 685928Z18A
Classification: IACT

CISATRACURIUM BESYLATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0409-5547
Application NumberANDA203236
Product Classification
M
Marketing Category
C73584
G
Generic Name
CISATRACURIUM BESYLATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 5, 2022
FDA Product Classification

INGREDIENTS (3)

BENZENESULFONIC ACIDInactive
Code: 685928Z18A
Classification: IACT
CISATRACURIUM BESYLATEActive
Quantity: 2 mg in 1 mL
Code: 80YS8O1MBS
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cisatracurium Besylate - FDA Drug Approval Details